175 related articles for article (PubMed ID: 2028924)
21. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR
Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin, 5-fluorouracil, and high-dose folinic acid in patients with advanced unresectable head and neck cancer.
Alba E; Sanchez-Chaparro MA; Alonso L; Ribelles N; Ramon Delgado J; Rueda A; Pablo Tenllado P; Solano J; Urquiza R
Am J Clin Oncol; 1996 Apr; 19(2):140-3. PubMed ID: 8610637
[TBL] [Abstract][Full Text] [Related]
23. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
[TBL] [Abstract][Full Text] [Related]
24. Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinoma.
Tellez-Bernal E; Belehradek M; Recondo G; Cvitkovic E; Leridant AM; Vericel R; Armand JP
Am J Clin Oncol; 1990 Oct; 13(5):452-4. PubMed ID: 1699403
[TBL] [Abstract][Full Text] [Related]
25. Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck.
Posner MR; Glisson B; Frenette G; Al-Sarraf M; Colevas AD; Norris CM; Seroskie JD; Shin DM; Olivares R; Garay CA
J Clin Oncol; 2001 Feb; 19(4):1096-104. PubMed ID: 11181674
[TBL] [Abstract][Full Text] [Related]
26. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
[TBL] [Abstract][Full Text] [Related]
27. [Neo-adjuvant chemotherapy with cisplatin, 5-fluorouracil, vindesine in head and neck cancer].
Terazono T; Oshima W; Kihira S; Takegami E; Kume T; Doi R; Nakao M; Takada A
Gan To Kagaku Ryoho; 1992 Feb; 19(2):211-5. PubMed ID: 1736833
[TBL] [Abstract][Full Text] [Related]
28. Combination of mitomycin, vindesine, and cisplatin in the treatment of head and neck squamous cell carcinoma.
Leyvraz S; Barrelet L; Savary M; Bernasconi S
Cancer Treat Rep; 1987 Jan; 71(1):81-2. PubMed ID: 3791271
[TBL] [Abstract][Full Text] [Related]
29. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
[TBL] [Abstract][Full Text] [Related]
30. Combination of daily 4-h infusion of 5-fluorouracil and cisplatin in the treatment of advanced head and neck squamous-cell carcinoma: a South-East European Oncology Group study.
Jassem J; Gyergyay F; Kerpel-Fronius S; Nagykálnai T; Baumöhl J; Verweij J; Vuletic L; Mechl Z; Drozd-Lula M; Jelic S
Cancer Chemother Pharmacol; 1993; 31(6):489-94. PubMed ID: 8453690
[TBL] [Abstract][Full Text] [Related]
31. Folinic acid plus 5-FU based chemotherapy in squamous cell carcinoma of the head and neck: Bologna experience.
Pannuti F; Guaraldi M; Martoni A; Melotti B; Morritti MG
Ann Oncol; 1993; 4 Suppl 2():45-8. PubMed ID: 7688983
[TBL] [Abstract][Full Text] [Related]
32. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
Schena M; Barone C; Birocco N; Dongiovanni D; Numico G; Colantonio I; Bertetto O
Cancer Chemother Pharmacol; 2005 Mar; 55(3):271-6. PubMed ID: 15592837
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of high-dose cisplatin and 5-FU infusion as initial therapy in advanced head and neck cancer.
Kish JA; Ensley JF; Jacobs JR; Binns P; al-Sarraf M
Am J Clin Oncol; 1988 Oct; 11(5):553-7. PubMed ID: 3177258
[TBL] [Abstract][Full Text] [Related]
34. Induction chemotherapy with cisplatin and continuous infusion 5-fluorouracil in locally far-advanced head and neck cancer.
Verweij J; de Jong PC; de Mulder PH; van der Broek P; Alexieva-Figusch J; van Putten WL; Schornagel JH; Ravasz LA; Snow GB; Vermorken JB
Am J Clin Oncol; 1989 Oct; 12(5):420-4. PubMed ID: 2801602
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant therapy for advanced head and neck cancer with allopurinol-modulated high dose 5-fluorouracil and cisplatin. A phase I-II study.
Greenberg B; Ahmann F; Garewal H; Koopmann C; Coulthard S; Berzes H; Alberts D; Shimm D; Slymen D
Cancer; 1987 Jun; 59(11):1860-5. PubMed ID: 3567849
[TBL] [Abstract][Full Text] [Related]
37. A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck.
Dasmahapatra KS; Citrin P; Hill GJ; Yee R; Mohit-Tabatabai MA; Rush BF
J Clin Oncol; 1985 Nov; 3(11):1486-9. PubMed ID: 4056841
[TBL] [Abstract][Full Text] [Related]
38. Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region.
Fountzilas G; Daniilidis J; Sridhar KS; Kalogera-Fountzila A; Zaramboukas T; Sombolos K; Destouni-Salem E; Vritsios A; Tourkantonis A
Cancer; 1990 Oct; 66(7):1453-60. PubMed ID: 1698526
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study.
Rowland KM; Taylor SG; Spiers AS; DeConti RC; O'Donnell MR; Showel J; Stott PB; Milner LM; Marsh JC
Cancer Treat Rep; 1986 Apr; 70(4):461-4. PubMed ID: 3698038
[TBL] [Abstract][Full Text] [Related]
40. Phase I-II trial of recombinant interferon alpha-2b with cisplatin and 5-fluorouracil in recurrent and/or metastatic carcinoma of head and neck.
Bensmaine ME; Azli N; Domenge C; Armand JP; Cvitkovic E
Am J Clin Oncol; 1996 Jun; 19(3):249-54. PubMed ID: 8638535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
